ASP Health recently marked a successful presence at the AABIP (American Association for Bronchology and Interventional Pulmonology) Annual Conference, where the company showcased its end-to-end ROSE solution to a national audience of interventional pulmonologists and clinical leaders.
During the conference, ASP Health demonstrated how its integrated ROSE platform supports rapid on-site evaluation at the point of care, addressing one of the most pressing challenges in interventional pulmonology today: limited access to cytology resources during procedures. The showcase highlighted how ASP Health’s technology enables seamless collaboration between pulmonology and pathology teams, even when expertise is not physically on site.
In conjunction with the conference, ASP Health hosted a ROSE Innovation Forum dinner, bringing together interventional pulmonologists and key opinion leaders from across the country. The forum provided an open setting for in-depth discussions on emerging trends in interventional pulmonology, evolving procedural demands, and the growing importance of real-time diagnostic support during bronchoscopic procedures.
Conversations throughout the evening reinforced the critical need for ROSE at the point of care. Attendees emphasized that timely adequacy assessment not only improves procedural efficiency but also enhances diagnostic confidence and patient outcomes. These discussions reaffirmed that ASP Health’s end-to-end ROSE solution is uniquely positioned to bridge cytology resource gaps while strengthening interdisciplinary collaboration between pulmonology and pathology teams.
“As procedures become more complex and volumes continue to grow, access to reliable ROSE is no longer optional—it’s essential,” ASP Health noted. “The feedback from AABIP underscored that a scalable, end-to-end approach to ROSE can fundamentally change how teams work together in real time.”
Looking ahead, ASP Health continues to advance its ROSE Assist platform, with a focus on delivering real-time, actionable data that supports better clinical decision-making. By partnering closely with healthcare leaders and frontline clinicians, ASP Health aims to further enhance workflow efficiency, diagnostic quality, and ultimately patient outcomes.
ASP Health’s engagement at AABIP reflects its ongoing commitment to innovation, collaboration, and the advancement of point-of-care diagnostics in interventional pulmonology.
